Showing results (31-40 of 71) with videos related to
Sort By:
Pageof 8
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|November 2, 2021
Neither Surgical Margin Status nor Somatic Mutation Predicts Local Recurrence After R0-intent Resection for Colorectal Liver MetastasesYujiro Nishioka, Natalia Paez-Arango, Federico Oppliger Boettcher, et al.Cancer Immunology, Immunotherapy : CII|February 20, 2016
A phase I/IIa clinical trial in stage IV melanoma of an autologous tumor-dendritic cell fusion (dendritoma) vaccine with low dose interleukin-2Julia M Greene, Erika J Schneble, Doreen O Jackson, et al.Familial Cancer|June 9, 2020
Chemoprevention in familial adenomatous polyposis: past, present and futurePhillip M Kemp Bohan, Gautam Mankaney, Timothy J Vreeland, et al.Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|January 22, 2022
Contemporary Assessment of Need for Palliative Bypass After Aborted Pancreatoduodenectomy Following Neoadjuvant TherapyTimothy J Vreeland, Phillip M Kemp Bohan, Timothy E Newhook, et al.Surgery|November 16, 2019
Early postoperative drain fluid amylase in risk-stratified patients promotes tailored post-pancreatectomy drain management and potential for accelerated dischargeTimothy E Newhook, Eduardo A Vega, Timothy J Vreeland, et al.Clinical Immunology (Orlando, Fla.)|July 21, 2018
Effects of HLA status and HER2 status on outcomes in breast cancer patients at risk for recurrence - Implications for vaccine trial designDoreen O Jackson, Francois A Trappey, G Travis Clifton, et al.Immunotherapy|February 24, 2018
Tumor lysate particle loaded dendritic cell vaccine: preclinical testing of a novel personalized cancer vaccineMark O Hardin, Timothy J Vreeland, Guy T Clifton, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 20, 2020
Results of a Randomized Phase IIb Trial of Nelipepimut-S + Trastuzumab versus Trastuzumab to Prevent Recurrences in Patients with High-Risk HER2 Low-Expressing Breast CancerG Travis Clifton, Diane Hale, Timothy J Vreeland, et al.Oncotargets and Therapy|June 9, 2021
Near Complete Pathologic Response to PD-1 Inhibitor and Radiotherapy in a Patient with Locally Advanced Pancreatic Ductal AdenocarcinomaPatrick M McCarthy, Matthew J Rendo, Matthew D Uy, et al.Pancreas|June 19, 2019
Benefit of Gemcitabine/Nab-Paclitaxel Rescue of Patients With Borderline Resectable or Locally Advanced Pancreatic Adenocarcinoma After Early Failure of FOLFIRINOXTimothy J Vreeland, Florencia McAllister, Sanaz Javadi, et al.Pageof 8